**PURPOSE:** Due to the critical impact of breast implant infection on quality of life of breast cancer patients, we have published the performance characteristics of an evidence-based protocol that significantly reduced but did not eliminate Gram-positive infection after mastectomy. To provide a skin barrier against bacterial contamination from the skin flora, we added the Alexis wound manager (AWM) to the evidence-based protocol at the time of immediate expander placement.

**METHODS:** An evidence-based protocol was developed including preoperative decolonization with intranasal Bactroban, and chlorhexidine body wash for 5 days, intraoperative double gloving with glove change, chest reprep before expander placement, triple and povidone iodine washes of implant and pocket and postoperative Gram-positive oral antibiotic prophylaxis until drain removal. In an effort to further decrease skin flora implant infections, an AWM was added to the protocol after our first 86 patients. All patients underwent immediate acellular dermal matrix--assisted, partially submuscular tissue expander placement with a single drain placed except when axillary lymph node dissection was performed resulting in 2 drains for that breast. A retrospective review of a prospectively maintained database of consecutive immediate breast tissue expander reconstructions was performed comparing demographics, treatment characteristics, and infection-related clinical outcomes of all patients completing the protocol with and without the AWM.

**RESULTS:** One hundred thirty-five breasts among 86 patients were reconstructed under the protocol alone, and 83 breasts among 46 patients were reconstructed under the same protocol with AWM. The 2 group of patients were statistically similar in age, body mass index, comorbid conditions, percentage of smokers, and rates of postoperative radiation. Overall (8.1%), major (2.9%) and minor (5.2%) infection rates were greater with the protocol alone than with the addition of the AWM (overall 7.2%, major 2.4%, and minor 4.8%), yet these differences were not significant. Explantation rates were higher as well in the protocol-only group (2.9%) than with the AWM (1.2%; *P* = 0.35). Drain duration was statistically significantly shorter with the AWM (12.6 days) than the protocol-alone group (17.6 days; *P* \< 0.01).

**CONCLUSIONS:** The use of a skin barrier as an addition to an evidence-based infection reduction protocol was associated with a modest improvement in infection outcomes and explantation rates and resulted in a significantly shorter drain duration.
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